DiscoverMoneycontrol Podcast2908: Coronavirus Essential | India's Covaxin may enter phase 3 trials in October; Bharat Biotech to make billion doses of intranasal vaccines
2908: Coronavirus Essential | India's Covaxin may enter phase 3 trials in October; Bharat Biotech to make billion doses of intranasal vaccines

2908: Coronavirus Essential | India's Covaxin may enter phase 3 trials in October; Bharat Biotech to make billion doses of intranasal vaccines

Update: 2020-09-24
Share

Description

Tune in to the Coronavirus Essential podcast with Sakshi Batra for all the news on the pandemic.
Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

2908: Coronavirus Essential | India's Covaxin may enter phase 3 trials in October; Bharat Biotech to make billion doses of intranasal vaccines

2908: Coronavirus Essential | India's Covaxin may enter phase 3 trials in October; Bharat Biotech to make billion doses of intranasal vaccines

moneycontrol